Abstract
Summary
Recombinant proteins are increasingly being used as defined supplements in biopharmaceutical, vaccine and stem cell manufacturing.
LPI (LP Information)' newest research report, the “Recombinant Cell Culture Supplements Industry Forecast” looks at past sales and reviews total world Recombinant Cell Culture Supplements sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Cell Culture Supplements sales for 2023 through 2029. With Recombinant Cell Culture Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Cell Culture Supplements industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Cell Culture Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Cell Culture Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Cell Culture Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Cell Culture Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Cell Culture Supplements.
The global Recombinant Cell Culture Supplements market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Cell Culture Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Cell Culture Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Cell Culture Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Cell Culture Supplements players cover BBI Solutions, Corning, Evercyte, Gemini Bio-Products, Lonza Group, Merck, Novozymes, Repligen and Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Cell Culture Supplements market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Recombinant Albumin
Recombinant Insulin
Recombinant Epidermal Growth Factor
Recombinant Transferrin
Others
Segmentation by application
Stem Cell and Regenerative Medicine
BioProduction
Academic and Research Application
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BBI Solutions
Corning
Evercyte
Gemini Bio-Products
Lonza Group
Merck
Novozymes
Repligen
Thermo Fisher Scientific
LPI (LP Information)' newest research report, the “Recombinant Cell Culture Supplements Industry Forecast” looks at past sales and reviews total world Recombinant Cell Culture Supplements sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Cell Culture Supplements sales for 2023 through 2029. With Recombinant Cell Culture Supplements sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Cell Culture Supplements industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Cell Culture Supplements landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Cell Culture Supplements portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Cell Culture Supplements market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Cell Culture Supplements and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Cell Culture Supplements.
The global Recombinant Cell Culture Supplements market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Cell Culture Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Cell Culture Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Cell Culture Supplements is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Cell Culture Supplements players cover BBI Solutions, Corning, Evercyte, Gemini Bio-Products, Lonza Group, Merck, Novozymes, Repligen and Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Cell Culture Supplements market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Recombinant Albumin
Recombinant Insulin
Recombinant Epidermal Growth Factor
Recombinant Transferrin
Others
Segmentation by application
Stem Cell and Regenerative Medicine
BioProduction
Academic and Research Application
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BBI Solutions
Corning
Evercyte
Gemini Bio-Products
Lonza Group
Merck
Novozymes
Repligen
Thermo Fisher Scientific
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Cell Culture Supplements Market Size 2018-2029
2.1.2 Recombinant Cell Culture Supplements Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Recombinant Cell Culture Supplements Segment by Type
2.2.1 Recombinant Albumin
2.2.2 Recombinant Insulin
2.2.3 Recombinant Epidermal Growth Factor
2.2.4 Recombinant Transferrin
2.2.5 Others
2.3 Recombinant Cell Culture Supplements Market Size by Type
2.3.1 Recombinant Cell Culture Supplements Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Recombinant Cell Culture Supplements Market Size Market Share by Type (2018-2023)
2.4 Recombinant Cell Culture Supplements Segment by Application
2.4.1 Stem Cell and Regenerative Medicine
2.4.2 BioProduction
2.4.3 Academic and Research Application
2.5 Recombinant Cell Culture Supplements Market Size by Application
2.5.1 Recombinant Cell Culture Supplements Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Recombinant Cell Culture Supplements Market Size Market Share by Application (2018-2023)
3 Recombinant Cell Culture Supplements Market Size by Player
3.1 Recombinant Cell Culture Supplements Market Size Market Share by Players
3.1.1 Global Recombinant Cell Culture Supplements Revenue by Players (2018-2023)
3.1.2 Global Recombinant Cell Culture Supplements Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant Cell Culture Supplements Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Recombinant Cell Culture Supplements by Regions
4.1 Recombinant Cell Culture Supplements Market Size by Regions (2018-2023)
4.2 Americas Recombinant Cell Culture Supplements Market Size Growth (2018-2023)
4.3 APAC Recombinant Cell Culture Supplements Market Size Growth (2018-2023)
4.4 Europe Recombinant Cell Culture Supplements Market Size Growth (2018-2023)
4.5 Middle East & Africa Recombinant Cell Culture Supplements Market Size Growth (2018-2023)
5 Americas
5.1 Americas Recombinant Cell Culture Supplements Market Size by Country (2018-2023)
5.2 Americas Recombinant Cell Culture Supplements Market Size by Type (2018-2023)
5.3 Americas Recombinant Cell Culture Supplements Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Cell Culture Supplements Market Size by Region (2018-2023)
6.2 APAC Recombinant Cell Culture Supplements Market Size by Type (2018-2023)
6.3 APAC Recombinant Cell Culture Supplements Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Recombinant Cell Culture Supplements by Country (2018-2023)
7.2 Europe Recombinant Cell Culture Supplements Market Size by Type (2018-2023)
7.3 Europe Recombinant Cell Culture Supplements Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Cell Culture Supplements by Region (2018-2023)
8.2 Middle East & Africa Recombinant Cell Culture Supplements Market Size by Type (2018-2023)
8.3 Middle East & Africa Recombinant Cell Culture Supplements Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Recombinant Cell Culture Supplements Market Forecast
10.1 Global Recombinant Cell Culture Supplements Forecast by Regions (2024-2029)
10.1.1 Global Recombinant Cell Culture Supplements Forecast by Regions (2024-2029)
10.1.2 Americas Recombinant Cell Culture Supplements Forecast
10.1.3 APAC Recombinant Cell Culture Supplements Forecast
10.1.4 Europe Recombinant Cell Culture Supplements Forecast
10.1.5 Middle East & Africa Recombinant Cell Culture Supplements Forecast
10.2 Americas Recombinant Cell Culture Supplements Forecast by Country (2024-2029)
10.2.1 United States Recombinant Cell Culture Supplements Market Forecast
10.2.2 Canada Recombinant Cell Culture Supplements Market Forecast
10.2.3 Mexico Recombinant Cell Culture Supplements Market Forecast
10.2.4 Brazil Recombinant Cell Culture Supplements Market Forecast
10.3 APAC Recombinant Cell Culture Supplements Forecast by Region (2024-2029)
10.3.1 China Recombinant Cell Culture Supplements Market Forecast
10.3.2 Japan Recombinant Cell Culture Supplements Market Forecast
10.3.3 Korea Recombinant Cell Culture Supplements Market Forecast
10.3.4 Southeast Asia Recombinant Cell Culture Supplements Market Forecast
10.3.5 India Recombinant Cell Culture Supplements Market Forecast
10.3.6 Australia Recombinant Cell Culture Supplements Market Forecast
10.4 Europe Recombinant Cell Culture Supplements Forecast by Country (2024-2029)
10.4.1 Germany Recombinant Cell Culture Supplements Market Forecast
10.4.2 France Recombinant Cell Culture Supplements Market Forecast
10.4.3 UK Recombinant Cell Culture Supplements Market Forecast
10.4.4 Italy Recombinant Cell Culture Supplements Market Forecast
10.4.5 Russia Recombinant Cell Culture Supplements Market Forecast
10.5 Middle East & Africa Recombinant Cell Culture Supplements Forecast by Region (2024-2029)
10.5.1 Egypt Recombinant Cell Culture Supplements Market Forecast
10.5.2 South Africa Recombinant Cell Culture Supplements Market Forecast
10.5.3 Israel Recombinant Cell Culture Supplements Market Forecast
10.5.4 Turkey Recombinant Cell Culture Supplements Market Forecast
10.5.5 GCC Countries Recombinant Cell Culture Supplements Market Forecast
10.6 Global Recombinant Cell Culture Supplements Forecast by Type (2024-2029)
10.7 Global Recombinant Cell Culture Supplements Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 BBI Solutions
11.1.1 BBI Solutions Company Information
11.1.2 BBI Solutions Recombinant Cell Culture Supplements Product Offered
11.1.3 BBI Solutions Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 BBI Solutions Main Business Overview
11.1.5 BBI Solutions Latest Developments
11.2 Corning
11.2.1 Corning Company Information
11.2.2 Corning Recombinant Cell Culture Supplements Product Offered
11.2.3 Corning Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Corning Main Business Overview
11.2.5 Corning Latest Developments
11.3 Evercyte
11.3.1 Evercyte Company Information
11.3.2 Evercyte Recombinant Cell Culture Supplements Product Offered
11.3.3 Evercyte Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Evercyte Main Business Overview
11.3.5 Evercyte Latest Developments
11.4 Gemini Bio-Products
11.4.1 Gemini Bio-Products Company Information
11.4.2 Gemini Bio-Products Recombinant Cell Culture Supplements Product Offered
11.4.3 Gemini Bio-Products Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Gemini Bio-Products Main Business Overview
11.4.5 Gemini Bio-Products Latest Developments
11.5 Lonza Group
11.5.1 Lonza Group Company Information
11.5.2 Lonza Group Recombinant Cell Culture Supplements Product Offered
11.5.3 Lonza Group Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Lonza Group Main Business Overview
11.5.5 Lonza Group Latest Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Recombinant Cell Culture Supplements Product Offered
11.6.3 Merck Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Merck Main Business Overview
11.6.5 Merck Latest Developments
11.7 Novozymes
11.7.1 Novozymes Company Information
11.7.2 Novozymes Recombinant Cell Culture Supplements Product Offered
11.7.3 Novozymes Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Novozymes Main Business Overview
11.7.5 Novozymes Latest Developments
11.8 Repligen
11.8.1 Repligen Company Information
11.8.2 Repligen Recombinant Cell Culture Supplements Product Offered
11.8.3 Repligen Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Repligen Main Business Overview
11.8.5 Repligen Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific Recombinant Cell Culture Supplements Product Offered
11.9.3 Thermo Fisher Scientific Recombinant Cell Culture Supplements Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion